TRITIUM LABELLING OF GEMFIBROZIL: ANTIBIOTICS & KILLING INTRACELLULAR BACTERIA

Gemfibrozil 的氚标记:抗生素

基本信息

项目摘要

Bacteria that grow inside cells, such as Legionella, Mycobacteria, Salmonella, and Listeria are hard to kill with certain antibiotics. Dr. Samuel Silverstein's laboratory may have a way to overcome the problem, using the cholesterol-lowering drug, gemfibrozil. Silverstein's group identified that gemfibrozil prevents the efflux of fluoroquinolone, an antibiotic, from infected cells, thereby increasing both the intracellular antibiotic concentration and the concentration of antibiotic to which the bacteria are exposed. Normally the antibiotic, which is an organic anion, gets ejected from the cell via an organic anion transporter. Because gemfibrozil blocks the transporter from ferrying the antibiotics out of the cell, the antibiotic then becomes available to kill the intracellular bacteria. (Journal of Experimental Medicine, 176, 1439 (1992)). His laboratory is in the process of identifying the transporter that carries the organic anion antibiotic. Its activity is found in mouse macrophage cell lines, mouse macrophage primary cultures, and primary human cultured monocytes that differentiate into macrophages. Studies of the use of other anionic antibiotics in bacterially infected mice are under way. Dr. Silverstein recently won a Guggenheim Award to study this anion transporter. A radioactive form of gemfibrozil was required to further this research. The base molecule was brominated by the action of bromine in the presence of acetic acid and sodium acetate. The brominated compound was dehalogenated to yield tritiated gemfibrozil of very high purity and specific activity, as shown by HPLC and NMR analyses.
生长在细胞内的细菌,如军团菌、分枝杆菌、

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MANOUCHEHR SALJOUGHIAN其他文献

MANOUCHEHR SALJOUGHIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MANOUCHEHR SALJOUGHIAN', 18)}}的其他基金

REDUCTIVE CLEAVAGE OF ALIPHATIC NITRO GROUPS W/ TRIBUTYLTIN TRITIDE: TRITIUM NMR
使用三丁基锡对脂肪族硝基进行还原裂解:氚 NMR
  • 批准号:
    6500498
  • 财政年份:
    2000
  • 资助金额:
    $ 0.69万
  • 项目类别:
RADICAL INDUCED DEAMINATION OF PRIMARY & SECONDARY AMINES BY TRIBUTYLTIN TRITIDE
自由基引发的初级脱氨
  • 批准号:
    6500500
  • 财政年份:
    2000
  • 资助金额:
    $ 0.69万
  • 项目类别:
TRITIUM LABELLING OF DNA & RNA BY CHEMICAL & ENZYMATIC SYNTHESIS
DNA 氚标记
  • 批准号:
    6500521
  • 财政年份:
    2000
  • 资助金额:
    $ 0.69万
  • 项目类别:
SYNTHESIS OF VERY HIGH SPECIFIC ACTIVITY N TRITIOACETOXYPHTHALIMIDE: TRITIUM NMR
极高比活度 N 三硫乙酰氧基邻苯二甲酰亚胺的合成:氚 NMR
  • 批准号:
    6500499
  • 财政年份:
    2000
  • 资助金额:
    $ 0.69万
  • 项目类别:
NOVEL SYNTHESIS & APPLICATIONS OF DIAZOMETHANE
新颖的综合
  • 批准号:
    6500502
  • 财政年份:
    2000
  • 资助金额:
    $ 0.69万
  • 项目类别:
TRITIUM LABELLING OF GEMFIBROZIL: ANTIBIOTICS & KILLING INTRACELLULAR BACTERIA
Gemfibrozil 的氚标记:抗生素
  • 批准号:
    6500522
  • 财政年份:
    2000
  • 资助金额:
    $ 0.69万
  • 项目类别:
SYNTHESIS & APPLICATIONS OF LABELLED FORMYLATING REAGENTS: AMINO ACIDS & PEPTIDE
合成
  • 批准号:
    6500501
  • 财政年份:
    2000
  • 资助金额:
    $ 0.69万
  • 项目类别:
NEW TRITIUM LABELLING REAGENTS & TECHNIQUES SYNTHESIS REVIEW ARTICLE
新型氚标记试剂
  • 批准号:
    6500532
  • 财政年份:
    2000
  • 资助金额:
    $ 0.69万
  • 项目类别:
NEW TRITIUM LABELLING REAGENTS & TECHNIQUES: SYNTHESIS REVIEW ARTICLE
新型氚标记试剂
  • 批准号:
    6119744
  • 财政年份:
    1998
  • 资助金额:
    $ 0.69万
  • 项目类别:
SYNTHESIS & APPLICATIONS OF LABELLED FORMYLATING REAGENTS: AMINO ACIDS & PEPTIDE
合成
  • 批准号:
    6220428
  • 财政年份:
    1998
  • 资助金额:
    $ 0.69万
  • 项目类别:

相似海外基金

Molecular Imaging Biomedical Resource Core
分子成像生物医学资源核心
  • 批准号:
    10747619
  • 财政年份:
    2023
  • 资助金额:
    $ 0.69万
  • 项目类别:
Biomedical Resource Core
生物医学资源核心
  • 批准号:
    10747705
  • 财政年份:
    2023
  • 资助金额:
    $ 0.69万
  • 项目类别:
Intravital Microscopy Biomedical Resource Core
活体显微镜生物医学资源核心
  • 批准号:
    10747618
  • 财政年份:
    2023
  • 资助金额:
    $ 0.69万
  • 项目类别:
Biomedical Resource Core
生物医学资源核心
  • 批准号:
    10754083
  • 财政年份:
    2023
  • 资助金额:
    $ 0.69万
  • 项目类别:
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
  • 批准号:
    10797623
  • 财政年份:
    2022
  • 资助金额:
    $ 0.69万
  • 项目类别:
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
  • 批准号:
    10653773
  • 财政年份:
    2022
  • 资助金额:
    $ 0.69万
  • 项目类别:
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
  • 批准号:
    10430665
  • 财政年份:
    2022
  • 资助金额:
    $ 0.69万
  • 项目类别:
The 1958 Birth Cohort Biomedical Resource - facilitating access to data and samples and enhancing future utility
1958 年出生队列生物医学资源 - 促进数据和样本的获取并增强未来的效用
  • 批准号:
    G1001799/2
  • 财政年份:
    2013
  • 资助金额:
    $ 0.69万
  • 项目类别:
    Research Grant
The 1958 Birth Cohort Biomedical Resource - facilitating access to data and samples and enhancing future utility
1958 年出生队列生物医学资源 - 促进数据和样本的获取并增强未来的效用
  • 批准号:
    G1001799/1
  • 财政年份:
    2011
  • 资助金额:
    $ 0.69万
  • 项目类别:
    Research Grant
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群
  • 批准号:
    7894014
  • 财政年份:
    2009
  • 资助金额:
    $ 0.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了